BridgeMD
Compares treatment options for Postoperative Pain
Official title Transversus Abdominis Plane Block Versus Wound Infiltration for Pulmonary Function Preservation Following Laparoscopic Living Donor Nephrectomy
ClinicalTrials.gov ID: NCT06837909
What this study is testing
- What it's testing
- This study compares two pain control techniques in patients undergoing laparoscopic kidney donation surgery: transversus abdominis plane (TAP) block versus wound infiltration with local anesthetic. Postoperative pain can impair breathing by causing patients to take shallow breaths to avoid discomfort.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients who are scheduled to undergo elective LLDN.
- Age above 18 years.
- Body Mass Index (BMI) above 20 and below 40 kg m-2.
- Eligible to sign informed consent.
You likely can't join if
- Open or hand-assisted surgery.
- Known cardiac or pulmonary disease.
- Preoperative chronic pain (i.e., fibromyalgia, chronic neuropathic pain).
- Contraindication for regional analgesia (i.e., known allergy to LA, skin lesions in the injection site).
- Known allergy to one or more of the components of multimodal analgesia (i.e., opioids, paracetamol, tramadol, dipyrone).
- Preexisting severe pulmonary disease (i.e., an obstructive lung disease with a forced expiratory volume in the first second [FEV1] below 49%...
See the full eligibility criteria
- Patients who are scheduled to undergo elective LLDN.
- Age above 18 years.
- Body Mass Index (BMI) above 20 and below 40 kg m-2.
- Eligible to sign informed consent.
- Open or hand-assisted surgery.
- Known cardiac or pulmonary disease.
- Preoperative chronic pain (i.e., fibromyalgia, chronic neuropathic pain).
- Contraindication for regional analgesia (i.e., known allergy to LA, skin lesions in the injection site).
- Known allergy to one or more of the components of multimodal analgesia (i.e., opioids, paracetamol, tramadol, dipyrone).
- Preexisting severe pulmonary disease (i.e., an obstructive lung disease with a forced expiratory volume in the first second [FEV1] below 49%, restrictive lung disease with a forced vital capacity [FVC] below 49%...
- Experience intraoperative bleeding requiring transfusion of more than three units of blood products.
- Experience hemodynamic instability requiring postoperative vasopressor or inotropic support.
- Require conversion to open surgery.
- Require mechanical ventilation after being transferred from the OR to the PACU.
The study team makes the final eligibility decision.
Where it's taking place
- Petah Tikva, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Petah Tikva, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.